504 related articles for article (PubMed ID: 22198801)
1. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
Tayeb HO; Yang HD; Price BH; Tarazi FI
Pharmacol Ther; 2012 Apr; 134(1):8-25. PubMed ID: 22198801
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
3. Effective pharmacological management of Alzheimer's disease.
Atri A
Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: a review of recent developments.
Salawu FK; Umar JT; Olokoba AB
Ann Afr Med; 2011; 10(2):73-9. PubMed ID: 21691010
[TBL] [Abstract][Full Text] [Related]
5. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
Franke AG; Lieb K; Fellgiebel A
Fortschr Neurol Psychiatr; 2009 Jun; 77(6):326-33. PubMed ID: 19504422
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer disease and its management: a review.
Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
Geerts H; Grossberg GT
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of memantine in the treatment of Alzheimer's disease].
Molinuevo Guix JL; Lladó Plarrumaní A
Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
[TBL] [Abstract][Full Text] [Related]
10. Galantamine for Alzheimer's disease.
Prvulovic D; Hampel H; Pantel J
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):345-54. PubMed ID: 20113148
[TBL] [Abstract][Full Text] [Related]
11. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
Schölzel-Dorenbos CJ;
Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
14. Realistic expectations for treatment success in Alzheimer's disease.
Geldmacher DS; Frolich L; Doody RS; Erkinjuntti T; Vellas B; Jones RW; Banerjee S; Lin P; Sano M
J Nutr Health Aging; 2006; 10(5):417-29. PubMed ID: 17066215
[TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment and preclinical Alzheimer's disease.
Morris JC
Geriatrics; 2005 Jun; Suppl():9-14. PubMed ID: 16025770
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Alzheimer's disease: the current situation?].
Jacquy J
Rev Med Brux; 2010 Sep; 31(4):357-62. PubMed ID: 21089415
[TBL] [Abstract][Full Text] [Related]
17. [Newly approved drugs for Alzheimer disease: effectiveness and limitation].
Yanagisawa K
Brain Nerve; 2011 Aug; 63(8):863-8. PubMed ID: 21817177
[TBL] [Abstract][Full Text] [Related]
18. Current and future therapy in Alzheimer's disease.
van Marum RJ
Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview.
Kumar A; Singh A; Aggarwal A
Indian J Exp Biol; 2017 Feb; 55(2):63-73. PubMed ID: 30183230
[TBL] [Abstract][Full Text] [Related]
20. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Grossberg GT
Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]